Florida International University
Edit Your Profile
FIU Discovery
Toggle navigation
Browse
Home
People
Organizations
Scholarly & Creative Works
Research Facilities
Support
GYNECOLOGIC ONCOLOGY
Journal
Overview
Research
Identifiers
Other
View All
Overview
publication venue for
Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors
. 140:138-144.
2016
Incidence of port site hernias in robotic and laparoscopy assisted procedures in gynecologic oncology
. 133:196.
2014
Is pharmacologic prophylaxis indicated for prevention of thromboembolic disease after robotic and laparoscopic hysterectomy in a gynecologic oncology practice? Analysis of morbidity and cost in 1335 cases
. 133:150.
2014
Non-cancer life stressors contribute to impaired quality of life in ovarian cancer patients
. 131:667-673.
2013
Vaginal cuff complications decreased in total robotic vs. laparoscopic hysterectomy in cancer and noncancer patients: Bidirectional barbed vs. conventional suture
. 130:e160.
2013
Multimodal therapy in the treatment of vaginal adenocarcinoma arising from endocervicosis
. 120:158-159.
2011
Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: A phase II study based on surgical reassessment
. 119:451-456.
2010
Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: A New York Cancer Consortium Study
. 116:442-446.
2010
A phase I study of docetaxel as a radio-sensitizer for locally advanced squamous cell cervical cancer
. 113:195-199.
2009
Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III
. 106:453-460.
2007
Uterine sarcoma occurring in a premenopausal patient after uterine artery embolization: A case report and review of the literature
. 104:260-263.
2007
Prolonged topotecan infusion with cisplatin in the first-line treatment of ovarian cancer: An NYGOG and ECOG study
. 100:324-329.
2006
Phase II trial of thalidomide for advanced and recurrent gynecologic sarcoma: A brief communication from the New York Phase II consortium
. 100:160-165.
2006
Sigmoid impaction secondary to urinary stones: Case report and review of literature
. 97:234-237.
2005
Conversion of an incontinent urinary conduit to a continent urinary reservoir (Miami Pouch)
. 94:814-817.
2004
Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study
. 93:144-148.
2004
Evaluation of low-dose intraperitoneal interferon-alpha for palliation of ascites in patients with non-ovarian gynecologic malignancies
. 89:420-423.
2003
Expression of glucose transporter-1 in cervical cancer and its precursors
. 86:138-143.
2002
Radical vaginal trachelectomy after supracervical hysterectomy
. 85:545-547.
2002
Vaginal reconstruction at the time of pelvic exenteration: A surgical and psychosexual analysis of techniques
. 87:39-45.
2002
Allelotype of papillary serous peritoneal carcinomas
. 82:69-76.
2001
Pattern of lymph node metastases in clinically unilateral stage invasive epithelial ovarian carcinomas
. 80:56-61.
2001
Colony-stimulating factor-1 and its receptor do not have a role in the pathogenesis of uterine sarcomas
. 74:202-207.
1999
A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancer
. 72:292-297.
1999
Primary uterine angiosarcoma
. 75:272-276.
1999
Continuous low-dose combined hormone replacement therapy and the risk of endometrial cancer
. 64:425-430.
1997
Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix
. 61:416-422.
1996
In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration
. 61:175-179.
1996
A PROSPECTIVE RANDOMIZED COMPARISON OF AN ATTACHED SILVER-IMPREGNATED CUFF TO PREVENT CENTRAL VENOUS CATHETER-ASSOCIATED INFECTION
. 58:92-100.
1995
A PHASE-I TRIAL OF CYCLOSPHOSPHAMIDE AND CARBOPLATINUM COMBINED WITH INTERLEUKIN-3 IN WOMEN WITH ADVANCED-STAGE OVARIAN-CANCER
. 56:387-394.
1995
LIPID-SOLUBLE ANTIOXIDANTS - BETA-CAROTENE AND ALPHA-TOCOPHEROL LEVELS IN BREAST AND GYNECOLOGIC CANCERS
. 55:72-77.
1994
PLATINUM CHEMOTHERAPY DURING PREGNANCY FOR SEROUS CYSTADENOCARCINOMA OF THE OVARY
. 49:92-94.
1993
ENDOMETRIAL ADENOCARCINOMA - GENETIC-ANALYSIS SUGGESTING HERITABLE SITE-SPECIFIC UTERINE-CANCER
. 47:167-171.
1992
LYMPH-NODE SAMPLING IN PATIENTS WITH EPITHELIAL OVARIAN-CARCINOMA
. 47:143-145.
1992
Endometrial adenocarcinoma: Genetic analysis indicating heritable site-specific uterine cancer
. 45:81.
1992
Lymph node sampling in patients with epithelial ovarian carcinoma
. 45:77.
1992
Pilot clinical trial of cisplatin (CDDP), radiation therapy (RT), and WR2721 in carcinoma of the uterine cervix (CC)
. 45:85.
1992
Surgical management of patients with endometrial cancer and cervical involvement
. 45:97-98.
1992
CA-125 - A POTENTIAL PROGNOSTIC INDICATOR IN PATIENTS WITH CERVICAL-CANCER
. 40:222-224.
1991
CA125-a potential prognostic indicator in patients with cervical carcinoma?
. 40:189.
1991
The role of anemia in predicting treatment outcome in locally advanced cervical carcinoma
. 40:186.
1991
A SUCCESSFUL TERM PREGNANCY FOLLOWING THE SYSTEMIC AND INTRAPERITONEAL ADMINISTRATION OF CISPLATIN CHEMOTHERAPY
. 39:378-380.
1990
HETEROGENEITY IN HORMONE RECEPTOR STATUS IN PRIMARY AND METASTATIC ENDOMETRIAL CANCER
. 38:437-441.
1990
OVARIAN CONSERVATION IN PLACENTAL SITE TROPHOBLASTIC TUMOR
. 37:239-243.
1990
CONCOMITANT CISPLATIN AND RADIOTHERAPY IN LOCALLY ADVANCED CERVICAL-CARCINOMA
. 34:395-401.
1989
ARTERIAL EMBOLIZATION IN THE MANAGEMENT OF ABDOMINAL AND RETROPERITONEAL HEMORRHAGE
. 34:131-135.
1989
COLPOSCOPIC AND CYTOLOGIC DETECTION OF CHRONIC LYMPHOCYTIC-LEUKEMIA
. 34:106-108.
1989
IMMUNE-COMPLEXES IN OVARIAN-CARCINOMA
. 32:350-353.
1989
Concomitant cisplatin (DDP) and radiotherapy (RT) in locally advanced cervical carcinoma (CX CA)
. 32:126-127.
1989
Incidence of clostridium difficile (CD) infection in patients (pis.) with diarrhea (D) on a gynecologic oncology service
. 32:120.
1989
CONTINUOUS INFUSION FLUOROPYRIMIDINES AS SALVAGE THERAPY FOR PATIENTS WITH ADVANCED OVARIAN-CARCINOMA
. 29:348-355.
1988
CATHETER COMPLICATIONS ASSOCIATED WITH INTRAPERITONEAL CHEMOTHERAPY
. 24:41-50.
1986
ELEVATION OF SERUM CA 125 PRIOR TO DIAGNOSIS OF AN EPITHELIAL OVARIAN-CARCINOMA
. 22:115-120.
1985
CA-125 is a useful predictor of disease status in uterine carcinosarcoma
2018
Education Forum I: Immunotherapy 2018: Updates and Toxicities Saturday, March 24, 2018
2018
Immune checkpoint blockade and a neoepitope vaccine in a metastatic ovarian cancer model
2018
Is VTE chemoprophylaxis beneficial after robotic hysterectomy with staging for uterine cancer? An analysis of prevalence, prophylaxis and Caprini risk assessment model among 332 patients
2017
Omental disease has a significant impact on overall survival in patients with uterine carcinosarcoma
2017
Unplanned postoperative intensive care unit admission for ovarian cancer cytoreduction is associated with significant decrease in overall survival
2017
Utility of indocyanine green (ICG) dye with Firefly fluorescence imaging alone or combined with methylene blue dye for detection of sentinel lymph nodes in endometrial and cervical cancer, and discriminative ability for detecting metastases
2017
Radical abdominal and robotic hysterectomy: Perioperative and oncologic outcome of 175 cases
2015
Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: A study of morbidity and survival
2004
The gastrointestinal complications of the Miami Pouch: A review of 77 cases
2004
Surgery "ain't" going to cut it. Are we ready?
2002
Profound thrombocytopenia in previously treated patients with recurrent ovarian carcinoma receiving topotecan
1998
CECAL CANCER IN A TEENAGER PRESENTING WITH A PELVIC MASS - A CASE-REPORT AND REVIEW OF THE LITERATURE
1994
ANALYSIS FOR STEROID-PRODUCTION OF A SERTOLI-LEYDIG CELL TUMOR
1994
Endometrial cancer: A review and current management strategies: Part I
2014
Endometrial cancer: A review and current management strategies: Part II
2014
The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer
2010
ADJUVANT THERAPY FOR NEUROENDOCRINE SMALL-CELL CARCINOMA OF THE CERVIX - REVIEW OF THE LITERATURE
1991
Fanconi anemia repair pathway as a predictor of anti-tumor activity of pembrolizumab: interim analysis of open-label, single-arm phase II trial
2021
Endometrial cancer: A review and current management strategies: Part I (vol 134, pg 385, 2014)
2014
Saul B.!Gusberg, MD. In memoriam
2005
TO P-32 OR NOT TO P-32, THAT IS THE QUESTION
1993
Research
category
OBSTETRICS & GYNECOLOGY
Category
ONCOLOGY
Category
Identifiers
International Standard Serial Number (ISSN)
0090-8258
Electronic International Standard Serial Number (EISSN)
1095-6859
Other
journal abbreviation
GYNECOL ONCOL
